2
Fo r T h e Medi c al Pro f e ss io n O nly E MOX® Capsu le s - Dry Mi x- Vi a ls Broa d Spe ctrum A ntib i o t i c C ompo si tion : Ea ch do s age un i t con ta ins : Amoxicillin Propertie s: E - Mox ( a mo x i cl lt i n ) is a s e m i synthetic , acid  steore . a m i no p e nicilli n and a n a na logue of a r np i d IIi r L I t i s a brea d-sp ectr u m ba ct eric i dal a gen t an d is i nactiv ated by pe nicillinase . It I S ac t J v e aga i nst a w i d e range of g ram pos iti ve and gram neg a t ive b ac teria i n c l ud i rg : S t a p hy t o c o oc i ( ' l O r I p e ni c i l ii nase- p r o duc i ng strains) , St r ep tococc us pn eumonia . . tae c a s s , S . V ln d a n s . Es ch e n chi a co li. H aemopbil us i nf luenza , Helico ba c ter p y lo r i , L i s t e ri a monocytog e ne s , Mor a x e ll a canarrhaiis , Ne i sse r i a gonorr h o e a e , N . men i ng i t i d i s , P r o t e u s n w a b i i s . a nd Sa l mone ll a spe c i es .  OX $ a cts b y i n hi b i ti ng m uc o p rot ei n s yn th es t s In m e c e l l w a D of ba ct e r i a It i s mor e rap i d l ya n d more co mp I ete t y a b sorbe d t h a n  w h en g iv e n by mo u th . Phannacokinetics : Amox i c i l li n i s rap id l y and a l mo s t c omplet e ty ab sorbe d a f te r oral adm i nis tra t i on . Pea p l asma - concentra tio ns have been observe d a tt e r1 - 2 h o urs . Doubling the d o se c an -- datiGie - the -- GOf 'l€ eAtf a t i oo . . . . -- F oo d - in  t he -- stGmach --- do es net dimi n ish t he - aoscrp t t cn ct - tha drug. C oncen tr at i o ns o f amoxi cil lin aft er 1 M injectio n a r e si mi l a r to those a chie v e d W i t h or al adm i n ist rat io n . Amoxtc l ttt i s wi d el y d i s tribute d a t v ar yi n g c o n ce n tra tion i n bo d y ti ssues a n d fluid s . It cross es t he p lac en ta; passes i nt o e CS F w h e n th e m e n i nges a r e Inft a m ed ; and sma ll amounts a re distri bu t ed int o brea st ' . Amo x i c il l in i s a b o u t 2 CR . bo u n d t o p l as m a p rot e in s . Iti s me t a bo l i zed i n the li ve r g ivvl g penicil l oic a c i d w h K :h i s e xcret ed i n t he ur i ne. Ab out 60% of a n oral d ose i s e x c r e t e d un chan ged in the u r i n e  6 h o ur s . H i gh conc en tr a tions hav e b een rep oned i n b i l e ; s o me may b ee x c re ted i n f aeces . P l asma ha l f - li ve s of 1 - 1 . 5 ho u rs hav e been rep o rted . T he h a H - l i fe may be pro k> og ed i n n e on a te s , th e e l d e rty , a nd r enal i m p a irm e nt . I n se v ere re n a l i mpa i rme n t , h aH- life i s 7 - 20 ho u r s . I nd ic a t i o ns : Tr ea t men t o f i n f ectio ns c a u s e db y sus c ep ti b le b acte r ia, i n clu d i ng : - Upper respir a t o ry t r a ct i n fect i o n s: o t it i s m e d ia , sin u si t i s , ton s " p h a r y ngitis , a nd lar yn g iti s . - L ow e r r esp i r ato ry tr a ct inf e ct i o n s : a c ute and c hr o n ic br o nch itis , a nd p n e u m oni a . - G as t r oint e stinal t ra ct i nf e ctions: t ypho i d a n d para t y p ho i d fe v e rs .  il i  ry tr act infec t i ons , a nd gastro e n er i t i s .. E r a o J c a  o n of He a ct e r py l ori . - Ge n i t o - u r i nary t r a ct i nf e ct i o ns . S k i n a n d s o ft t i s su e i n fe c ti o ns . - P rophy t ax i s of bact er i a l e ndoc a rd i t i s. Dose s an d Ad m inist ra t i on : • Ora l adm i n istr a tion: Adu lt s : 500 mg e very 8 hours . Children up t o 10 y ea r s : 1 25 - 2 50 m g e v er y 8 hours : C hi l d re n u nd er 4 kg body we ight : 20 - 40 mg l kg da ily in di vi ded d o ses every 8 ho ur s , o r 25 - 45 mg ll< ; g dail yi n divid e d dos e s e v er y 1 2h o urs . H igher or a l d o s es , e ither a s a s i ngle dose or in sho t c o urses , m a y be us ed as fo ll o w s: F or de n ta l a bscess e s: 3 gm repeated onc e atter 8 h o urs . Unco mp l icate d a cute u r i na ry-tract i nfec ti on s : 3 gm repeat e d onc e a f t e r 1 0 - 12 ho u r s . Seve re or r e curr en t i nf e ctions o f r esp i r a t ory trac t : 3 gm t w ic e d a ily . C h il d r en aged 3 - 1 0y ea rs w i th oti t i s med ia : 75 0 m g tw i ce da ily fo r 2 days . U nco mp lic ated go norrho e a : A si ng l ed ose of 3 gm a moxiciUi n , wi t h 1 gm p ro benec i d . Pr o p hy l ax i s of e n docard iti s : 2 - 3 gm i s g iv en ab o u t 1 ho u r be f ore dent a l procedures . E rad i catio n o f H . p ylo r i : E - M OX f ;  i s g iv e n w i t h e ith e r metr n i d az ol e or cl ar i th r omycin a n d gastr ic se c re t i on in h ib i tor or ran iti d in e b i sm uth compound , i n d o ses of 0 . 75 - 1 . 00 gm tw i ce d aily or 5 00 mg 3 ti me s daily. . R eco n sti t ution of [ " M OX  D r y Mi x: T o m ake up . f i rst shake th e bot t l e to l oose n p o w der , then add w a ter t o t he c o ntent of t he bottl e and s h ake w ell . Fill u p to th e lin e a nd allow to st a nd f o r 5 m in utes to e n s u r e full d i sper si on. After re constitut i on , E - M O X  s cx pe nst cn s houl d b e s to red in a re fri gera tor a n d us ed only wit h in 10 da y s . Shake w e ll before use . - Par ent era l adm i n i stra t i o n : B y 1 M or s lo w IV i n ject i on Adults : 5 0 mg every 8 hours . In sever e infect i on s , 1 gm e v er y hours by s lo w IV inject i on o v e r 3 - 4 minutes or by in fu si on  v r 30 - 60 m inute s . C hi  r en a ge up  'f a y ea rs :  ) <r = TOomg i' l(g - da ily " i n - d ivi de d - d o ses  . - - D o ses m a y be r educed i n r e nal imp a i r m e nt . Drug I nterac ti on s : Te ra cyc : i ne . s may i nh i b i t ac tivi ty of a mox i ci lli n . P r o b e o e c i ::: i pro l o n g s e a cti vi t y of a mox i c ill i n . Pr ecautions: •. E - YO X - . s h o u l d De us e e c a u t i o n i n : o f  a . E 9 Y s um a s ecae- t a , h a y f e v e r , and a a ) . -s..-.  y  fu nd i on . - k I s: . ;x y c e v . a lo s o o nn  g y   or L a ct a . X N l . Con tr aind ic a ti o ns : _ _ H ypersen § :it i , { itY J o penicillins . . ; ..,. - Inf ec ti o us mononucleosis . Sid e Ef fe c t s: As w ith o th er p e n i c il l i n s , s i de eff e cts m ay in c lu d e hy pe rs e n s i t ivi ty { r as h , a n a phy t a x i s l , s upe r i nfectio n , d i arrh o ea , n a u s e a , vomi ti ng , pseudomemb r a n o u s c o li t i s ( r a r e ) , h emo t yt i c anem i a . e o sinoph ili a ; a gr anulocytos i s ( rare ) ; pru r i t u s , and ur tic ar i a . Packag i ng : E - M OX i & 500 m g C ap sules : B li s t er s of 8 capsul e s ea ch . E - M O X i  l 12 5 mg D ry Mix : B ott l e of 60 m l o r 100 mt su spension a fte r reco nsti tut i on . E . .- M OX i l 250 mg Dry ix: B ottl e of 60 m l o r 100 ml susp ens i o n after r e con st itution. E. .- MOX i l 25 mg V i als : B ox of 1vi al . E-MOX i l 500 mg Vials: Box o f 1 vial . E - MO X O  l l 9 Vials : B ox o f 1 vi a l . TUsi . tI. Me <  lC aff i e Ot i s a p ro d uc t wh i m af f ects you r h ea lth , a nd it s con su mp tio n cont r ar y to m st ru c nc es is danger ous lor y ou . -  o u w st ri c tl y t h e doctor's pres c r i p ti on , the me t hod of u s e , a nd t h e inst uctio ns of theph a rmac i st w ho s ol d the me d i c am e n t . -T h e doctor an d m e ph ar m a ci st ar e ex per ts in m ed i c i ne . i t s b e nef i t s a n d r is ks . - Do n ot i n terr upt the per i od of t rea t ment p r e scri bed b y y ours e l f - Do n otre pea t t h e samep r escr i ption w i thout c o nsu l t i ng yo u r doct or . -xeec me di c ines ou t ofthe reachofch il dre n. 2  9 ·2  5 PM S: Black C . 16X16CM 5 6 g/m2 131 3 PAM 00 0 E E EEEE EE EEE EE E E E E E E EE E E EEEEEEE EE EEEEEEEEE EE EE EE EE E EEEE E E E EEEEEEEEE EGYPTIANINT.PHARMACEUTICAL INDUSTRI ES CO E.1 . P.1 . CO . 10 th OF R AMADAN CIT Y , A REA Bl P . O . BOX149T E NTH , EGYPT

E MOX PIL

Embed Size (px)

Citation preview

Page 1: E MOX PIL

7/23/2019 E MOX PIL

http://slidepdf.com/reader/full/e-mox-pil 1/1

For The Medical Profession Only

E MOX®

Capsules - Dry Mix - Vials

Broad Spectrum Antibiotic

Composition:

Each dosage unit contains:

Amoxicillin

Properties:

E-Mox (amoxiclltin) is a semisynthetic, acid

 steore.

aminopenicillin and an analogue of

arnpidIIirL It is a

bread-spectrum bactericidal

agent

and

is

inactivated by penicillinase.

It

IS

actJve against a wide range of gram positive and gram negative bacteria includirg:

Staphytocooci (l'lOrIpeniciliinase- producin g stra ins), Streptococcus pneumonia. S. taecass,

S.Vlndans.

Eschenchia coli.

Haemopbilus

influenza,

Helicobacter

pylori, Listeria

monocytogenes, Moraxella canarrhaiis, Neisseria gonorrhoeae, N.meningitidis, Proteus

nwabiis.

and Salmonella species.

 OX$

acts by

inhibiting mucoprotein synthests

In

me cell

waD

of

bacteria

It is

more rapidly and

more compIetety

absorbed

than  

when given by mouth.

Phannacokinetics:

Amoxicillin is rapidly and almost completety absorbed after oral administration. Pea

plasma-concentrations have been observed atter 1 - 2 hours. Doubling the dose can

--datiGie-the--GOf'l€eAtfatioo....--Food-in  the--stGmach---does net diminish the-aoscrpttcn ct-tha

drug. Concentrations of amoxicillin after 1M injection are similar to those achieved With oral

administration. Amoxtcltttn is widely distributed at varying concentration in body tissues

and fluids. It crosses the placenta; passes into e CSF when the meninges are Inftamed;

and small amounts are distributed into breast '. Amoxicillin is about 2CR. bound to

plasma proteins. It is metabolized in the liver givvlg penicilloic acid whK:h is excreted in the

urine. About 60% of an oral dose is excreted unchanged in the urine   6 hours. High

concentrations have been reponed in bile; some may be excreted in faeces. Plasma half-

lives of 1-1.5 hours have been reported. The haH-life may be prok>oged in neonates, the

elderty, and renal impairment. In severe renal impairment, haH-life is 7 - 20 hours.

Indications:

Treatment of infections caused by susceptible bacteria, including:

- Upper respi ratory tract infections: otitis media, sinusitis, tons " pharyngitis, and

laryngitis.

- Lower respiratory tract infections: acute and chronic bronchitis, and pneumonia.

- Gastrointestinal tract infections: typhoid and paratyphoid fevers.

 ili ry

tract i nfections,

and gastroen eritis..

• EraoJc a o n

of He acter pylori.

- Genito-urinary tract infections.

• Skin and soft tissue infections.

- Prophytaxis of bacterial endocarditis.

Doses and Administration:

• Oral administration:

Adults: 500 mg every 8 hours.

Children up to 10 years: 125 - 250 mg every 8 hours:

Children under 40 kg body weight: 20 - 40

mglkg

daily in divided doses every 8 hours, or

25 - 45 mgll<;g daily in divided doses every 12 hours.

Higher oral doses, either as a single dose or in short courses, may be used as follows:

For dental abscesses: 3 gm repeated once atter 8 hours.

Uncomplicated acute urinary-tract infections: 3 gm repeated once after 10 - 12 hours.

Severe or recurrent infections of respiratory tract: 3 gm twice daily.

Children aged 3 - 10 years with otitis media: 750 mg twice daily for 2 days.

Uncomplicated gonorrhoea: A single dose of

3

gm amoxiciUin, with 1 gm probenecid.

Prophylaxis of endocarditis: 2 - 3 gm is given about 1 hour before dental procedures.

Eradication of H.pylori: E-MOX f;  is given with either metronidazole or clarithromycin and

gastric secretion inhibitor or ranitidine bismuth compound, in doses of 0.75 - 1.00 gm

twice daily or 500 mg

3

times daily. .

Reconstitution of ["MOX   Dry Mix:

To make up. fir st shake the bottle to loosen powder, then add water to the content of the

bottle and shake well. Fill up to the line and allow to

stand

for

5

minutes to ensure full

dispersion.

After reconstitution,

E-MOX  scxpenstcn

should be stored in a refrigerator and used

only w ithin 10 days. Shake well before use.

- Parenteral administration:

By 1M or slow IV injection

Adults: 500 mg every 8 hours. In severe infections, 1 gm every 6 hours by slow IV

injection over 3 -

4

minutes or by infusion

 v r

30 - 60 minutes.

Chi  ren age up   'fa years:  ) <r=TOomgi'l(g-daily"in-divided-doses  . --

Doses may be reduced in renal impairment.

Drug Interactions:

• Te racyc:ine.s may inhibit activity of amoxicillin.

• Probeoeci:::i

prolongs e

activity

of

amoxicillin.

Precautions:

•.E-YOX- .shouldDe usee caution in:

of   a .E 9Y sum as ecae-ta, hay fever, and a a).

-s..-. y  

fundion.

- kIs: .;x y cev.alosoonn  gy 

•   or Lacta.XNl.

Contraindications:

__ • Hypersen§:iti,{itYJo penicillins..;..,.

- Infectious mononucleosis.

Side Effects:

As with other penicillins, side effects may include hypersensitivity {rash, anaphytaxisl,

superinfection, diarrhoea, nausea, vomiting, pseudomembranous colitis (rare), hemotytic

anemia. eosinophilia; agranulocytosis (rare); pruritus, and urticaria.

Packaging:

E-MOX i& 500 mg Capsules: Blisters of 8 capsules each.

E-MOXi l 125 mg Dry Mix: Bottle of 60 ml or 100 mt suspension after reconstitution.

E..-MOXi l 250 mg Dry Mix: Bottle of 60 ml or 100 ml suspension after reconstitution.

E..-MOXi l 250 mg Vials: Box of 1 vial.

E-MOXi l 500 mg Vials: Box of 1 vial.

E-MO XO l l

9 Via ls: Box of 1 vial.

TUsi.tI.

-Me< lCaffieOt is a product whim affects your health, and its consumption contrary to mstrucnces

is dangerous lor you.

-   o u w strictly the doctor's prescription, the method of use, and the ins tructions of the pharmacist

who sold the medicament.

-The doctor and me pharmacist are experts in medicine. its benefits and risks.

-Do not interrupt the period of treatment prescribed by yourself

-Do no t repeat the same prescription without consulting your doctor.

-xeec medicin es out o f t he reach o f children.

2  9·2  5

PMS: Black C.16X16CM 56 g/m2131

3

PAM000

EEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE

EGYPTIAN INT. PHARMACEUTICAL INDUSTRIES CO.

E.1. P.1. CO.

10

th

OF RAMADAN CITY, AREA Bl P.O.BOX 149TENTH, EGYPT